1. Home
  2. BBW vs DAWN Comparison

BBW vs DAWN Comparison

Compare BBW & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBW
  • DAWN
  • Stock Information
  • Founded
  • BBW 1997
  • DAWN 2018
  • Country
  • BBW United States
  • DAWN United States
  • Employees
  • BBW N/A
  • DAWN N/A
  • Industry
  • BBW Recreational Games/Products/Toys
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBW Consumer Discretionary
  • DAWN Health Care
  • Exchange
  • BBW Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • BBW 672.6M
  • DAWN 624.8M
  • IPO Year
  • BBW 2004
  • DAWN 2021
  • Fundamental
  • Price
  • BBW $73.85
  • DAWN $7.28
  • Analyst Decision
  • BBW Strong Buy
  • DAWN Strong Buy
  • Analyst Count
  • BBW 5
  • DAWN 7
  • Target Price
  • BBW $66.80
  • DAWN $27.86
  • AVG Volume (30 Days)
  • BBW 421.0K
  • DAWN 1.1M
  • Earning Date
  • BBW 08-28-2025
  • DAWN 10-29-2025
  • Dividend Yield
  • BBW 1.18%
  • DAWN N/A
  • EPS Growth
  • BBW 25.62
  • DAWN N/A
  • EPS
  • BBW 4.47
  • DAWN N/A
  • Revenue
  • BBW $522,518,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • BBW $6.35
  • DAWN $12.56
  • Revenue Next Year
  • BBW $2.04
  • DAWN $48.02
  • P/E Ratio
  • BBW $16.70
  • DAWN N/A
  • Revenue Growth
  • BBW 8.10
  • DAWN 2190.50
  • 52 Week Low
  • BBW $29.32
  • DAWN $5.64
  • 52 Week High
  • BBW $75.23
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • BBW 71.97
  • DAWN 54.04
  • Support Level
  • BBW $58.90
  • DAWN $7.18
  • Resistance Level
  • BBW $75.23
  • DAWN $7.58
  • Average True Range (ATR)
  • BBW 3.69
  • DAWN 0.26
  • MACD
  • BBW 1.38
  • DAWN -0.02
  • Stochastic Oscillator
  • BBW 92.88
  • DAWN 43.27

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: